Pintas & Mullins Law Firm

Blog Posts in May, 2016

  • Breast Cancer Survivors Face a Lifetime of Taxotere Toxicity

    Women diagnosed with breast cancer face incredible obstacles and overcome overwhelming odds on their road to recovery. Among those obstacles is chemotherapy, which notoriously causes patients to lose their hair temporarily. What patients don’t know is that with one specific chemo drug – Taxotere – hair may never return. In some women, Taxotere kills hair follicles with no way to reverse the ...
    Continue Reading
  • The Real Cost of Medical Mistakes in America

    A study recently found that over 250,000 Americans die from medical mistakes every year, making it the third-leading cause of death. Our medical malpractice lawyers have been representing victims of medical errors for 30 years. Here, we shed some light on this hotly debated issue and share what we’ve learned over the last three decades. Why the Hot Debate? Any number of factors can cause medical ...
    Continue Reading
  • New Bladder Cancer Drug Approved

    We recently wrote about a new, growing type of cancer center focused on immunotherapy and collaboration between top doctors. Our Actos attorneys are happy to report that a new immunotherapy drug, Tecentriq, has been approved to treat bladder cancer. As our Actos bladder cancer clients know, there have not been any important improvements in bladder cancer treatment in many years. Tecentriq is an ...
    Continue Reading
  • Bicycle Safety in Chicago

    It’s officially bicycling season in Chicago. While Mayor Rahm Emanuel takes action to make Chicago the most bike-friendly city in the country, our team of bike crash lawyers offer advice on navigating city streets safely. As always, we are available to speak to accident victims free of charge, seven days a week. According to our friends at Advocates Law in Washington, last year cycling accounted ...
    Continue Reading
  • Advancements in Lung Cancer Research and Drug Trials

    Our lung cancer lawyers strive to stay on top of the ever-evolving advancements in cancer research, treatment and development. Recently, three big-name investors have invested hundreds of millions of dollars on new cancer institutions. Clinical trials focused on immunotherapy are also offering a new hope for individualized treatments. Below, we detail what we’ve learned and how it could affect our ...
    Continue Reading
  • Abilify Side Effects Now Officially Include Uncontrollable Urges

    Our Abilify lawyers are currently accepting cases involving compulsive behavior. The FDA recently added warnings to Abilify’s labels detailing the drug’s link to uncontrollable urges for sex, gambling, shopping, and eating. Abilify (aripiprazole) is prescribed to treat depression, bipolar disorder, and schizophrenia, among other mental disorders. It is prescribed to approximately 1.6 million ...
    Continue Reading
  • Ovarian Cancer Plaintiff Wins $55 Million against Johnson & Johnson

    A woman in Missouri won $55 million in the second ovarian cancer trial against baby powder manufacturer Johnson & Johnson. Baby powder is made from talcum powder, and is linked to ovarian cancer when used genitally. Our talcum powder attorneys are representing women diagnosed with ovarian cancer nationwide. This is the second talc cancer lawsuit to go to trial this year, and the second ...
    Continue Reading
Page 1 of 1